U.K., Aug. 3 -- San Francisco, California-based Lemonaid Health provides telemedicine services and prescription drug delivery in the US.
The company's platform features physicians augmented with the assistance of algorithms to receive care for conditions such as UTIs, birth control, anxiety and more. Originally a direct-to-consumer provider, it said interest driven by COVID-19 has led it to also start working with partners.
Since its foundation in 2013, the company has raised over $53mn across five funding rounds. Its latest Series B, announced at the end of last week, raised $33mn from lead investor Olive Tree Ventures, alongside Sierra Ventures, Hikma Ventures, Correlation Ventures and Artis Ventures.
In a press release, Paul Johnson, ...